Australia's Imricor rises as Q1 revenue sees near fourfold jump
23/04/2025 02:20
** Shares of Imricor IMR.AX rise 5.71% to A$1.48, their biggest intraday pct gain since April 11 ** The medical device developer says its consumables revenue in Q1 up 385% Y-O-Y at $104,000 ** Stock hits its highest level since April 16 ** Stock up 8.82% this year, including the day's move (Reporting by Roushni Nair in Bengaluru) ((Roushni.nair@thomsonreuters.com;))
Recent news on Imricor Medical Systems
See all newsBrief: Imricor Medical Systems Says FDA Completes Review Of Imricor's Third PMA Module
Brief: Imricor Medical Systems Says FDA Accepts Imricor Pma Manufacturing Module
Brief: Imricor Medical Systems Says Anticipated FDA Clearances Of Additional Capital Equipment Expected To Broaden Product Offering Available To U.S. Customers
Imricor Medical Systems hits 3-month high on securing first US hospital customer
Brief: Imricor Medical Systems, Receives FDA 510(K) Clearance For Northstar Pediatric Label Expansion